drugset / Trial / NCT02369523

Multimodal Pain Management Following Primary TKA

NCT02369523

Phase 0 Terminated 84 enrolled University of Utah
RandomizedParallel-groupOpen-labelOther

Summary

The investigators plan to evaluate the length of time to discharge readiness between the groups (continuous femoral nerve blocks (cFNB) vs. liposomal bupivacaine (LB) vs. periarticular infusion cocktails (PIC) following primary total knee arthroplasty (TKA). In addition, the investigators will compare quadriceps strength recovery over time and exploratory variables between the groups.

Timeline

Start
2014-09
Primary completion
2017-04
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.125 % Other
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Bupivacaine Other / unclassified 20 ml Other
Comparator Ropivacaine Other / unclassified 400 mg Other
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Epinephrine Other / unclassified 0.4 mg
Comparator Epinephrine Other / unclassified
Comparator Morphine Other / unclassified 5 mg

Indications

No indication recorded.